Sonendo® Acquires Portfolio of Novel Dental Procedure Technology Patents

Sonendo®, Inc., a leading dental technology company and developer of the GentleWave® System, today announced the acquisition of all the assets of FluidFile Ltd., an Israeli dental company.
FluidFile is a specialist endodontic company that has developed a range of options for alternative root canal treatments. The assets included within the transaction primarily consist of a patent portfolio of 24 granted patents and pending patent applications with global reach relating to fluid motion technology in dental procedures. This transaction furthers Sonendo's strategic objective to transform the way in which root canals are treated. Sonendo's intellectual property portfolio covering cleaning and disinfecting in dentistry now includes over 119 patents worldwide and supports Sonendo's mission to improve patients' quality of life by saving teeth and stopping the progression of tooth decay
"This acquisition is an important investment in our business and our future. The FluidFile patents complement Sonendo's current patent portfolio and strengthen our already strong intellectual property position. We look forward to leveraging our intellectual property portfolio for unique product offerings that we expect will provide better and more efficient patient care and further adoption for our GentleWave technology," said Sonendo President and CEO Bjarne Bergheim.
Sonendo's GentleWave Procedure represents the next wave in the evolution of endodontic technology and can improve the patient experience. The GentleWave Procedure is designed to deliver more thorough cleaning and disinfection to the entire root canal system —even in the microscopic places where bacteria can hide—and leave more of the tooth structure intact^1,2. Most GentleWave Procedures can be performed in one visit, and in general, patients have found the procedure to be comfortable³. Additionally, the GentleWave System is designed to generate virtually no aerosolized material into the air during normal use⁴, which has become an important issue for clinicians and patients during the COVID-19 pandemic due to the heightened sensitivity to the concerns associated with cross-contamination via aerosol. Procedure instruments for the GentleWave System also come pre-sterilized and are single-use, further minimizing the risk of exposure from one patient to the next.
For more information about Sonendo visit sonendo.com. For information about TDO visit tdo4endo.com.
References
¹Sigurdsson A et al. (2016) J Endod. 42:1040-48. ²Molina B et al. (2015) J Endod. 41:1701-05. ³Sigurdsson et al. J Endod 2018; 44(3):510-517. ⁴Data on file at Sonendo; internal testing report #TR20-002.